A

BMP4-driven morphogenetic reprogramming sustains EGFR-TKI resistance via SOX2 suppression and EMT activation

Biomedicine & Pharmacotherapy

Authors 0

  1. Author list not loaded yet.

Cited by 0 stored of 0

References 1

1 result